BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8838776)

  • 1. Analysis of paired ordered categorical data in a factorial design.
    Patel HI; Tsai KT
    J Biopharm Stat; 1996 Mar; 6(1):15-36. PubMed ID: 8838776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials.
    Davis CS; Chung Y
    Biometrics; 1995 Sep; 51(3):1163-74. PubMed ID: 7548700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A linear model method for rank measures of association from longitudinal studies with fixed conditions (visits) for data collection and more than two groups.
    Jung JW; Koch GG
    J Biopharm Stat; 1998 May; 8(2):299-316. PubMed ID: 9598424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantel-Haenszel-type inference for cumulative odds ratios with a stratified ordinal response.
    Liu IM; Agresti A
    Biometrics; 1996 Dec; 52(4):1223-34. PubMed ID: 8962452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Order-restricted tests for stratified comparisons of binomial proportions.
    Agresti A; Coull BA
    Biometrics; 1996 Sep; 52(3):1103-11. PubMed ID: 8805770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and inference for an ordinal effect size measure.
    Ryu E; Agresti A
    Stat Med; 2008 May; 27(10):1703-17. PubMed ID: 17918752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous confidence intervals using ordinal effect measures for ordered categorical outcomes.
    Ryu E
    Stat Med; 2009 Nov; 28(25):3179-88. PubMed ID: 19691062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and analysis of trials with quality of life as an outcome: a practical guide.
    Walters SJ; Campbell MJ; Lall R
    J Biopharm Stat; 2001; 11(3):155-76. PubMed ID: 11725929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tests of significance using regression models for ordered categorical data.
    Snapinn SM; Small RD
    Biometrics; 1986 Sep; 42(3):583-92. PubMed ID: 3567291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
    Liu C; Shen W; Xie J
    Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonparametric inference in factorial designs with censored data.
    Akritas MG; LaValley MP
    Biometrics; 1996 Sep; 52(3):913-24. PubMed ID: 8805761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global odds ratio regression model for bivariate ordered categorical data from ophthalmologic studies.
    Williamson J; Kim K
    Stat Med; 1996 Jul; 15(14):1507-18. PubMed ID: 8855477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quasi-symmetric latent class models, with application to rater agreement.
    Agresti A; Lang JB
    Biometrics; 1993 Mar; 49(1):131-9. PubMed ID: 8513099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of an outcome using trajectories estimated from a linear mixed model.
    Maruyama N; Takahashi F; Takeuchi M
    J Biopharm Stat; 2009 Sep; 19(5):779-90. PubMed ID: 20183443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.
    Sullivan LM; D'Agostino RB
    Stat Med; 2003 Apr; 22(8):1317-34. PubMed ID: 12687657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mixed-effects regression model for three-level ordinal response data.
    Raman R; Hedeker D
    Stat Med; 2005 Nov; 24(21):3331-45. PubMed ID: 16206246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.